Cagrilintide & Semaglutide Stack (1:1 Ratio)10mg+10mg – Comparative Study on Energy Homeostasis
£77.99 – £291.79Price range: £77.99 through £291.79
A professional dual-peptide blend of Cagrilintide and Semaglutide. Synergistic formula for comprehensive metabolic and weight research.
Description
What is Cagri-Sema & CAS 1415456-99-3 / 910463-68-2?
As the landscape of metabolic science shifts toward multi-receptor agonists, Cagri-Sema stands at the forefront of this transition. This advanced research compound is a precise co-formulation of two potent peptides: Cagrilintide (a long-acting amylin analogue) and Semaglutide (a GLP-1 receptor agonist). By combining these two distinct chemical identities, researchers are able to study the simultaneous modulation of insulin secretion and glucagon suppression alongside amylin-mediated satiety signaling.
High-precision research begins with verified chemical identity. By utilizing rigorous vacuum-sealing and lyophilization protocols, 99Purity-Peptide offers a secure supply of this dual-peptide blend for global laboratory use. This commitment to purity ensures that our Cagri-Sema remains a reliable subject for investigating multi-pathway weight regulation and systemic metabolic homeostasis.
Cagri-Sema Mechanism of Action and Research
The research significance of Cagri-Sema lies in its dual-mechanism approach to metabolic signaling. Semaglutide (CAS 910463-68-2) functions by mimicking the GLP-1 hormone to enhance glucose-dependent insulin secretion and slow gastric emptying. Cagrilintide (CAS 1415456-99-3) complements this by acting as a non-selective amylin receptor agonist, which further promotes satiety and regulates meal-time glucose levels. Scientific interest focuses on whether the combination of these two pathways yields a synergistic effect that exceeds the efficacy of either peptide used in isolation.
Current longitudinal studies are exploring Cagri-Sema’s impact on total energy expenditure and its ability to achieve “weight set-point” recalibration. Because it targets both the gut-brain axis (via GLP-1) and the pancreatic hormone pathways (via amylin), it has become a foundational subject for the next generation of metabolic syndrome research.
Trending Research Topics & High-Authority Insights:
Amylin and GLP-1 Co-Agonism: Investigating the synergistic satiety signals in the hypothalamus.
Dual-Peptide Metabolic Optimization: Studies on energy intake vs. energy expenditure in dual-agonist models.
Cagri-Sema Specifications
| Feature | Specification |
| Product Name | Cagri-Sema (Cagrilintide + Semaglutide) |
| Available Strengths | 2.5mg+2.5mg, 5mg+5mg, 10mg+10mg |
| Physical Appearance | White Lyophilized Powder |
| Purity | ≥ 99% (HPLC/MS Verified) |
| Molecular Formula | $C_{180}H_{282}N_{50}O_{56}$ (Cagri) / $C_{187}H_{291}N_{45}O_{59}$ (Sema) |
| CAS Numbers | 1415456-99-3 & 910463-68-2 |
| Verification | 3rd-Party Lab Tested with COA |
| Storage Instructions | Store at -20°C (Long-term); 2-8°C after reconstitution |
Cagri-Sema Key Features & Benefits
Advanced Dual-Action Peptide Blend: Simultaneously targets GLP-1 and Amylin receptors for comprehensive metabolic data.
Synergistic Weight Research Subject: Optimized for studies investigating the combined effect of multiple appetite-regulation pathways.
Elite Laboratory Purity: Synthesized at 99%+ purity to eliminate variables and ensure reproducible experimental results.
Vacuum-Sealed Stability: Lyophilized format ensures the structural integrity of both peptides remains intact during transit.
Independently Lab-Verified: Every batch is confirmed via HPLC and Mass Spectrometry to guarantee exact concentration and identity.
Cagri-Sema Research FAQ
Why is Cagri-Sema considered superior to single-agonist research?
In metabolic models, targeting a single pathway often leads to physiological plateaus. Researchers study Cagri-Sema because the dual-pathway approach targets different areas of the brain and gut, potentially resulting in more significant metabolic shifts and sustained satiety observations.
What is the advantage of the 10mg+10mg high-dose blend?
The 10mg+10mg concentration provides a high-potency ratio that is ideal for advanced protocols or larger study groups, ensuring consistent dosing across the research duration without frequent vial changes.
How should this dual-peptide powder be handled?
As a blend of two distinct peptides, gentle handling is critical. After reconstitution with bacteriostatic water, the vial should be swirled gently (never shaken) and stored at 2-8°C to prevent peptide degradation.
Is the ratio of Cagrilintide to Semaglutide guaranteed?
Yes. 99Purity-Peptide provides a detailed COA for every batch, using analytical testing to confirm the precise 1:1 ratio and 99%+ purity of each component in the blend.
Why Buy Cagri-Sema online from 99Purity-Peptide?
Pioneering Biotech Formulations: We specialize in high-demand research blends, ensuring that our Cagri-Sema offers the most advanced toolset for your metabolic studies.
Discreet & Secure Global Logistics: Your research privacy is a priority. All orders are sent in neutral, secure packaging with tracked delivery to the USA, UK, and Europe.
Consistent Batch-to-Batch Quality: Our specialized manufacturing ensures that the chemical profile of our blends remains identical every time, supporting credible and valid research data.
Total Transparency: From 3rd-party lab verification to 1-2 business day dispatch, we provide the professional reliability that modern biotech researchers require.
Payment Support & Logistics
Secure Payment Options: We support multiple secure gateways, including Credit Cards, Cryptocurrency (USDT, USDC), PayPal, and Bank Transfers.
Global Shipping: Fast, tracked delivery available to the United States, United Kingdom, and Europe.
Processing Time: All orders are professionally handled and dispatched within 1-2 business days after payment confirmation.
Regulatory Disclaimer
99Purity-Peptide is a chemical supplier. We are not a compounding pharmacy or an outsourcing facility as defined under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act). All products are strictly for research, laboratory, or analytical use only and are NOT for human consumption.
References & Academic Links
Enebo, B. A., et al. (2021). “Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of cagrilintide and semaglutide.” The Lancet.
Frias, J. P. (2022). “Newer generation incretin-based therapies in the management of obesity and type 2 diabetes.” Expert Opinion on Investigational Drugs.
Additional information
| Weight | 0.5 kg |
|---|---|
| Dimensions | 25 × 20 × 20 cm |
| Strength | (2.5mg+2.5mg)*10Vials, ( 5mg+5mg)*10Vials, (10mg+10mg)*10Vials |
Related products
-

Liraglutide 30mg – High-Purity Acylated Peptide for Metabolic Signaling Research
£86.97 – £608.16Price range: £86.97 through £608.16 Select options This product has multiple variants. The options may be chosen on the product page -

Adipotide (FTTP) 10mg – Prohibitin-Targeted Endothelial Apoptosis Research
£72.88 – £295.79Price range: £72.88 through £295.79 Select options This product has multiple variants. The options may be chosen on the product page -

Aicar 50mg – High-Purity Nucleoside Signaling Standard for Metabolic Research
£84.47 – £199.65Price range: £84.47 through £199.65 Select options This product has multiple variants. The options may be chosen on the product page -

AOD9604 10mg – Non-Lipogenic Signaling & Adipose Metabolism Modeling Research
£41.43 – £208.86Price range: £41.43 through £208.86 Select options This product has multiple variants. The options may be chosen on the product page








Reviews
There are no reviews yet.